OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perspectives on the Role of Isoliquiritigenin in Cancer
Kai-Lee Wang, Ying-Chun Yu, Shih‐Min Hsia
Cancers (2021) Vol. 13, Iss. 1, pp. 115-115
Open Access | Times Cited: 107
Kai-Lee Wang, Ying-Chun Yu, Shih‐Min Hsia
Cancers (2021) Vol. 13, Iss. 1, pp. 115-115
Open Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology
Shadma Wahab, Sivakumar Annadurai, Shahabe Saquib Abullais, et al.
Plants (2021) Vol. 10, Iss. 12, pp. 2751-2751
Open Access | Times Cited: 191
Shadma Wahab, Sivakumar Annadurai, Shahabe Saquib Abullais, et al.
Plants (2021) Vol. 10, Iss. 12, pp. 2751-2751
Open Access | Times Cited: 191
DYRK1A inhibitors for disease therapy: Current status and perspectives
Tong Liu, Yuxi Wang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114062-114062
Closed Access | Times Cited: 72
Tong Liu, Yuxi Wang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114062-114062
Closed Access | Times Cited: 72
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 37
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 37
Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Ziyi Chen, Wenwen Ding, Xiaoxue Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117059-117059
Closed Access | Times Cited: 26
Ziyi Chen, Wenwen Ding, Xiaoxue Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117059-117059
Closed Access | Times Cited: 26
Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation
Shuai Lu, Xibo Sun, Zhongbao Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Shuai Lu, Xibo Sun, Zhongbao Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Glycolysis, the sweet appetite of the tumor microenvironment
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith A. Clements, et al.
Cancer Letters (2024) Vol. 600, pp. 217156-217156
Open Access | Times Cited: 7
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith A. Clements, et al.
Cancer Letters (2024) Vol. 600, pp. 217156-217156
Open Access | Times Cited: 7
The “Ins and Outs and What-Abouts” of H2A.Z: A Tribute to C. David Allis
Felix Diegmüller, Jörg Leers, Sandra B. Hake
Journal of Biological Chemistry (2025) Vol. 301, Iss. 2, pp. 108154-108154
Open Access
Felix Diegmüller, Jörg Leers, Sandra B. Hake
Journal of Biological Chemistry (2025) Vol. 301, Iss. 2, pp. 108154-108154
Open Access
Role of Phytonutrients in Nutrigenetics and Nutrigenomics Perspective in Curing Breast Cancer
Tanima Bhattacharya, Soumam Dutta, Rokeya Akter, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1176-1176
Open Access | Times Cited: 43
Tanima Bhattacharya, Soumam Dutta, Rokeya Akter, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1176-1176
Open Access | Times Cited: 43
Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator
Zhu Zhang, Ken Kin Lam Yung, Joshua Ka-Shun Ko
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1349-1349
Open Access | Times Cited: 36
Zhu Zhang, Ken Kin Lam Yung, Joshua Ka-Shun Ko
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1349-1349
Open Access | Times Cited: 36
Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization
Yameng Cui, Yu‐Lin Wu, Cong Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154299-154299
Closed Access | Times Cited: 35
Yameng Cui, Yu‐Lin Wu, Cong Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154299-154299
Closed Access | Times Cited: 35
The licorice flavonoid isoliquiritigenin attenuates Mycobacterium tuberculosis-induced inflammation through Notch1/NF-κB and MAPK signaling pathways
Jinxia Sun, Qingwen Zhang, Gui‐Zhen Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115368-115368
Closed Access | Times Cited: 33
Jinxia Sun, Qingwen Zhang, Gui‐Zhen Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115368-115368
Closed Access | Times Cited: 33
Powerful Synergy of Traditional Chinese Medicine and Aggregation-Induced Emission-Active Photosensitizer in Photodynamic Therapy
Feiyi Sun, Hanchen Shen, Qingqing Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18952-18964
Closed Access | Times Cited: 19
Feiyi Sun, Hanchen Shen, Qingqing Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18952-18964
Closed Access | Times Cited: 19
Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells
Zeyu Wang, Weijian Li, Xue Wang, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 18
Zeyu Wang, Weijian Li, Xue Wang, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 18
Comprehensive compositional assessment of bioactive compounds in diverse pea accessions
Xiumei Han, Leonid Akhov, Paula Ashe, et al.
Food Research International (2023) Vol. 165, pp. 112455-112455
Open Access | Times Cited: 16
Xiumei Han, Leonid Akhov, Paula Ashe, et al.
Food Research International (2023) Vol. 165, pp. 112455-112455
Open Access | Times Cited: 16
Phytochemicals against Osteoarthritis by Inhibiting Apoptosis
Hui Kong, Juanjuan Han, D.О. Gorbachev, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1487-1487
Open Access | Times Cited: 6
Hui Kong, Juanjuan Han, D.О. Gorbachev, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1487-1487
Open Access | Times Cited: 6
Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance
Jiaying Cai, Xiyue Tan, Qichao Hu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3233-3253
Open Access | Times Cited: 5
Jiaying Cai, Xiyue Tan, Qichao Hu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3233-3253
Open Access | Times Cited: 5
Oxidative Processes and Xenobiotic Metabolism in Plants: Mechanisms of Defense and Potential Therapeutic Implications
Caterina Vicidomini, Rosanna Palumbo, Maria Moccia, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 4, pp. 1541-1569
Open Access | Times Cited: 5
Caterina Vicidomini, Rosanna Palumbo, Maria Moccia, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 4, pp. 1541-1569
Open Access | Times Cited: 5
The trojan horse strategy in T-ALL therapy by engineering T-ALL-derived exosomes for targeted delivery of Isoliquiritigenin to the bone marrow to conquer Drug-Resistant T-ALL in PDX model
Yong Liu, Lindi Li, Cheng Ouyang, et al.
Chemical Engineering Journal (2025), pp. 159379-159379
Open Access
Yong Liu, Lindi Li, Cheng Ouyang, et al.
Chemical Engineering Journal (2025), pp. 159379-159379
Open Access
Therapeutic Effects of Natural Products in the Treatment of Chronic Diseases: The Role in Regulating KEAP1–NRF2 Pathway
Yaling Li, X G Wang, Shuyue Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-30
Closed Access
Yaling Li, X G Wang, Shuyue Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-30
Closed Access
Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
Waimao Gao, Guang Yang, Xinjuan Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Waimao Gao, Guang Yang, Xinjuan Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Isoliquiritigenin Ameliorates High-Fat Diet-Induced Obesity in Mice by Activating Brown Adipose Tissue
Le Zhao, Minhao Li, Qingjun Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1616-1616
Open Access
Le Zhao, Minhao Li, Qingjun Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1616-1616
Open Access
Chemical Analysis and Antioxidant Activities of Resin Fractions from Pistacia lentiscus L. var. Chia in Neuroblastoma SH-SY5Y Cells
Achilleas Georgantopoulos, Foteini D. Kalousi, Federica Pollastro, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 997-997
Open Access
Achilleas Georgantopoulos, Foteini D. Kalousi, Federica Pollastro, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 997-997
Open Access
Licorice Extract Isoliquiritigenin Increased Cytosol Calcium and Induced Apoptosis in Colon Cancer Cells via Transient Receptor Potential Vanilloid‐1
Lin Wang, Qing Li, Lai K. Leung, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Lin Wang, Qing Li, Lai K. Leung, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 33
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 33
